Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21078810 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation
Conditions: Fibrillation, Atrial;   Atrial Fibrillation
Interventions: Drug: omega-3-acid ethyl esters;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.